Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX® Multi-Cord Study
Date:9/7/2011

I of development for the treatment of Peyronie's disease, in phase IIa of development for the treatment of Frozen Shoulder syndrome (Adhesive Capsulitis) and is in phase Ib of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy). Auxilium also has rights to pursue additional indications for XIAFLEX. For additional information, visit http://www.auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the use of concurrent multiple injections of XIAFLEX to treat several joints in the same hand at the same time; the completion of the analysis of trial data;  publication of full results of the study in an appropriate medical journal; a planned clinical trial to assess multiple concurrent injections of XIAFLEX; products in development for Peyronie's disease, Frozen Shoulder syndrome and cellulite; and the potential for XIAFLEX to be used in multiple indications.  

Forward-looking statements often address Auxilium's expected future financial position or business strategy and plans and objectives of management for future operations. Forward-looking statements provide Auxilium's current expectations or forecasts of future events. Auxilium's performance and financial results could differ materially from those reflected in these forward-looking statements due to various risks and uncertainties.

A more detailed list and description of the risks and uncertainties that Auxilium faces may be found under the heading "Risk Factors" in Auxilium's Annual Report on Form 10-K for the year ended December 31, 2010 and Form 10-Q for the quarter ended June 30, 2011, which are on file with the Securities and Exchange Commission. Given these risks and uncertainties, any or all of the
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
2. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
3. Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
4. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
5. Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011
6. Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytrens Contracture
7. Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
8. Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care Conference
9. Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX® in EU by Pfizer
10. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
11. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Nephros, Inc. (OTC Bulletin Board: ... that develops and sells high performance liquid purification ultrafilters, ... In addition, the concurrent temporary reduction in exercise price ... 17, 2013. Nephros estimates that it will ... offering.   A portion of the proceeds will be used ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
(Date:5/23/2013)... AUSTIN, Texas , May 23, 2013  Texas, ... organization to deliver doctors the survival tools they need ... and compete in today,s health care marketplace. ... Care will save local practices," said Stephen ... Medical Association (TMA). " Texas doctors ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... 1, 2011 Iverson Genetic Diagnostics, Inc. announced today that ... R eduction f or A dults ... initiated in major hospital systems nationwide to assess the utility ... individual patients to reduce their risk of serious bleeding or ...
... Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced that ... Monday, March 7, 2011 at 4:30 p.m. Eastern Time/1:30 p.m. ... business update, review fourth quarter and full year 2010 results, ... webcast and press release may be accessed from the Investors ...
Cached Medicine Technology:WARFARIN Study Launched to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 2WARFARIN Study Launched to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 3
(Date:5/24/2013)... (PRWEB) May 24, 2013 American Career ... education community, proudly participated in festivities surrounding the 2013 ... The event provided the perfect backdrop to introduce the ... 236 E. 3rd Street, housed in an architectural gem ... , ACC was an active exhibitor throughout the weekend ...
(Date:5/24/2013)... of five medical students have an unconscious bias against ... authors, from Wake Forest Baptist Medical Center, noted the ... of obesity. They concluded that teaching medical students to ... the millions of Americans who are overweight or obese. ... relationship, and even a patient,s willingness or desire to ...
(Date:5/24/2013)... 2013, Paris, France: Transcatheter aortic valve implantation (TAVI) is ... experience based on first results from a multicentre Asian ... "TAVI has become a treatment option for selected ... are virtually all from North American or European centres," ... Center, Singapore, told the conference. He explained that it ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The producers of ... air dates for Charlotte, North Carolina. It is one of ... Fortune 500 companies. The city is populated with more than ... which cover residents in both North and South Carolina. Viewers ... things medically-related can tune into WAXN-TV 64 Eyewitness News during ...
(Date:5/24/2013)... May 24, 2013 Electric™ Energy Straws, an ... IndyCar Rookie Carlos Munoz and will be the lead sponsor ... at the Indianapolis Motor Speedway. Munoz, who is part of ... of 228.342 mph in race, qualifying to be named the ... first row in Sunday’s race. , While Munoz is ...
Breaking Medicine News(10 mins):Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Many Medical Students Have Anti-Fat Bias, Study Finds 2Health News:Registry confirms TAVI efficacy and safety in Asian patients 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3
... of Bulletin News, LLC, announced today the launch of ... the members of the American Society of Clinical Oncology (ASCO). ... Friday to more than 20,000 ASCO members -- physicians and ... of people living with cancer. Daily Cancer News ...
... for the upper airway may improve sleep disorder symptoms, study ... throat exercises may help people with mild to moderate obstructive ... , A three-month program helped reduce OSA severity by 40 ... low oxygen saturation levels in blood, sleepiness, snoring and poor ...
... Children,s Hospital Boston launched a new Technology Development Fund aimed at ... medical devices. , ... Boston, MA (Vocus) May 8, ... Technology Development Fund aimed at advancing promising early-stage hospital technologies, ...
... May 8 Anthem Blue Cross announced today that it ... Cross to bring aid to Californians in the Santa Barbara ... continues to burn and threaten homes. In addition, Anthem announced ... affected by the fire. Prescriptions: Anthem ...
... who,d been tormented, , , FRIDAY, May 8 (HealthDay News) ... younger are more likely than others their age to ... report. , Their study involved 6,437 youths, who averaged ... provided regular updates about the youngsters, health and development ...
... May 8 The ,Help is Here Express, bus ... of May 11 - May 15 at various cities ... information on programs that provide prescription medicines for free ... hitting 7.5 percent, the Partnership for Prescription Assistance (PPA) ...
Cached Medicine News:Health News:Custom Briefings Launches E-Newsletter for the American Society of Clinical Oncology 2Health News:Exercising Throat Muscles May Relieve Sleep Apnea 2Health News:Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund 2Health News:Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund 3Health News:Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund 4Health News:Anthem Blue Cross to Support Members and Communities Impacted by Santa Barbara Fires 2Health News:Bullying Seems to Affect Kids Years Later 2Health News:Partnership for Prescription Assistance Prepared to Help Colorado Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Colorado Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Colorado Workers Hurt by Recession 4
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The electrically active helix of CapSureFix Novus lead is designed to extend easily for active fixation and retract for venous passage....
The Medtronic Model 6495 bipolar coaxial temporary pacing lead is designed to provide the advantages of bipolar technology based on the sensing and pacing capabilities of the Medtronic Model 6500 uni...
Medicine Products: